TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) has announced its plans to attend host more trade show exhibits in Q1 2022; the company noted it made the decision based on the success it saw from business-to-business (“B2B”) trade shows attended in 2021. According to the announcement, the company entered several new wholesaler relationships and received first-time purchase orders independent of sales from is regular retail channels because of its trade show participation. In addition, the company’s flagship product, TAAT(TM), earned the title Best New Product and took second place as Best in Show overall at last year’s The HQ Event. The company plans to participate in at least six events in the coming weeks. “As demand from consumers persists for alternatives to regular tobacco cigarettes, buyers in the convenience category are repeatedly tasked with scouting out new and innovative offerings that still provide an enjoyable experience,” said TAAT CEO Setti Coscarella in the press release. “This is a vicious cycle, as the many ‘new spins’ on alternatives such as vaping rarely get repeat purchases after smokers simply decide to go back to tobacco cigarettes. For this reason, TAAT stands right out in a trade show setting as a combustible product with the unique properties of no nicotine and no tobacco. When we began exhibiting at B2B trade shows last July, it became very clear that this was an ideal setting for capturing new wholesale accounts who can place TAAT in new markets across the United States. Aside from the fact that our immersive trade show booth setup conveys the value proposition of TAAT exceptionally well in a matter of seconds, the buyers are often ready to place an order on the spot. In fact, at many shows it is common for them to place the order and remit payment in the same interaction, with their order dispatched shortly thereafter. We are excited to be ramping up this strategy in 2022, by exhibiting at even more trade shows throughout the country.”
To view the full press release, visit https://ibn.fm/RU7E3
About TAAT Global Alternatives Inc.
TAAT Global Alternatives has developed TAAT, which is a tobacco-free and nicotine-free alternative to traditional cigarettes that is offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco(TM), a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion global tobacco industry. For more information, please visit www.TAATGlobal.com.
NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.
